Singapore: Quintiles has started its first global study involving Indonesia, made possible by an exclusive alliance with...
Singapore: Cytori Therapeutics announced that a 40-patient, multi-center investigator-sponsored and funded clinical stu...
Singapore: Clinical Network Services (CNS), an Australia-based CRO offering integrated development services in the plann...
Singapore: Australian CRO, Clinical Network Services (CNS), has acquired the business assets of its erstwhile New Zealan...
Singapore: Vedic Lifesciences launched an innovative and unique client-CRO model, called ACElerator, for conducting huma...
Singapore: Patient recruitment in phase II CALM trial has accelerated significantly in the past three months with 25 pa...
Singapore: AtCor Medical, developer and marketer of the SphygmoCor system which measures central aortic blood pressures ...
Bangalore: The Association for the Accreditation of Human Research Protection Programs, announced that it has accredit...
Bangalore: RCC Laboratories, a Hyderabad based contract research organization (CRO) and ViruSure entered into a partners...
Singapore: Quintiles and dabl, a provider of centralized ambulatory blood pressure measurement (ABPM) services, have en...
Singapore: Alchemia announced that the independent Data Safety Monitoring Board (DSMB) responsible for reviewing the sa...
Singapore: China-based WuXiPRA, a contract research organization (CRO), has appointed Mr James Pusey, as president and g...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International, ha...
Singapore: Trifecta Clinical joined the board of directors for the Asia Training Consortium (ATC), which is a group of ...
What are the major issues confronting India's bioscience sector now? On top of every one's mind is the uncertainty over ...
Singapore: Swiss drugmaker Roche announced that it has started late-stage trials of its experimental drug, Lampalizumab....
Singapore: PharmaNet/i3, inVentiv Health's clinical segment, and a leading provider of clinical development services to ...
